Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®

TORONTO, May 1, 2026 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), Canada's largest Canadian‑based global health company, today announced that Health Canada has approved Apo‑Semaglutide InjectionTM, a generic equivalent of Ozempic® (semaglutide injection). As the first...